JP2003528617A - ヒト以外の動物を遺伝子修飾するための新規なベクター - Google Patents
ヒト以外の動物を遺伝子修飾するための新規なベクターInfo
- Publication number
- JP2003528617A JP2003528617A JP2001570810A JP2001570810A JP2003528617A JP 2003528617 A JP2003528617 A JP 2003528617A JP 2001570810 A JP2001570810 A JP 2001570810A JP 2001570810 A JP2001570810 A JP 2001570810A JP 2003528617 A JP2003528617 A JP 2003528617A
- Authority
- JP
- Japan
- Prior art keywords
- linker
- human
- cell
- animal
- sperm
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000013598 vector Substances 0.000 title claims abstract description 36
- 238000012239 gene modification Methods 0.000 title abstract description 9
- 230000005017 genetic modification Effects 0.000 title abstract description 9
- 235000013617 genetically modified food Nutrition 0.000 title abstract description 9
- 241001465754 Metazoa Species 0.000 claims abstract description 57
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 50
- 108091033319 polynucleotide Proteins 0.000 claims abstract description 31
- 102000040430 polynucleotide Human genes 0.000 claims abstract description 31
- 239000002157 polynucleotide Substances 0.000 claims abstract description 31
- 230000004720 fertilization Effects 0.000 claims abstract description 22
- 238000000338 in vitro Methods 0.000 claims abstract description 22
- 238000001727 in vivo Methods 0.000 claims abstract description 21
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 21
- 230000003993 interaction Effects 0.000 claims abstract description 20
- 239000002502 liposome Substances 0.000 claims abstract description 19
- 102000004196 processed proteins & peptides Human genes 0.000 claims abstract description 14
- 108090000765 processed proteins & peptides Proteins 0.000 claims abstract description 14
- 229920001184 polypeptide Polymers 0.000 claims abstract description 13
- 235000013336 milk Nutrition 0.000 claims abstract description 7
- 210000004080 milk Anatomy 0.000 claims abstract description 7
- 239000008267 milk Substances 0.000 claims abstract description 7
- 230000009878 intermolecular interaction Effects 0.000 claims abstract description 6
- 210000000056 organ Anatomy 0.000 claims abstract description 6
- 238000002689 xenotransplantation Methods 0.000 claims abstract description 5
- 210000004027 cell Anatomy 0.000 claims description 129
- 108020004414 DNA Proteins 0.000 claims description 53
- 238000000034 method Methods 0.000 claims description 42
- 210000001161 mammalian embryo Anatomy 0.000 claims description 13
- 108060003951 Immunoglobulin Proteins 0.000 claims description 8
- 102000018358 immunoglobulin Human genes 0.000 claims description 8
- 102000053602 DNA Human genes 0.000 claims description 6
- 230000008878 coupling Effects 0.000 claims description 5
- 238000010168 coupling process Methods 0.000 claims description 5
- 238000005859 coupling reaction Methods 0.000 claims description 5
- 102000018997 Growth Hormone Human genes 0.000 claims description 4
- 108010051696 Growth Hormone Proteins 0.000 claims description 4
- 238000002054 transplantation Methods 0.000 claims description 4
- 241000124008 Mammalia Species 0.000 claims description 3
- 201000010099 disease Diseases 0.000 claims description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 3
- 239000000122 growth hormone Substances 0.000 claims description 3
- 244000052769 pathogen Species 0.000 claims description 3
- 239000002773 nucleotide Substances 0.000 claims 2
- 125000003729 nucleotide group Chemical group 0.000 claims 2
- 230000001717 pathogenic effect Effects 0.000 claims 2
- 210000004602 germ cell Anatomy 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 abstract description 7
- 230000012010 growth Effects 0.000 abstract description 5
- 230000002349 favourable effect Effects 0.000 abstract description 3
- 208000035240 Disease Resistance Diseases 0.000 abstract description 2
- 206010034133 Pathogen resistance Diseases 0.000 abstract description 2
- 239000013612 plasmid Substances 0.000 description 23
- 241000282887 Suidae Species 0.000 description 18
- 241000699666 Mus <mouse, genus> Species 0.000 description 15
- 230000027455 binding Effects 0.000 description 13
- 241000287828 Gallus gallus Species 0.000 description 11
- 241000699670 Mus sp. Species 0.000 description 11
- 238000006243 chemical reaction Methods 0.000 description 10
- 235000013601 eggs Nutrition 0.000 description 10
- 235000018102 proteins Nutrition 0.000 description 10
- 241000283707 Capra Species 0.000 description 9
- 238000000684 flow cytometry Methods 0.000 description 9
- 241000283690 Bos taurus Species 0.000 description 8
- 241001494479 Pecora Species 0.000 description 8
- 102000002260 Alkaline Phosphatase Human genes 0.000 description 7
- 108020004774 Alkaline Phosphatase Proteins 0.000 description 7
- 241000282898 Sus scrofa Species 0.000 description 7
- 239000000427 antigen Substances 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 230000009261 transgenic effect Effects 0.000 description 7
- 108091007433 antigens Proteins 0.000 description 6
- 102000036639 antigens Human genes 0.000 description 6
- 238000002105 Southern blotting Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 108091029865 Exogenous DNA Proteins 0.000 description 4
- 101710163270 Nuclease Proteins 0.000 description 4
- 210000002257 embryonic structure Anatomy 0.000 description 4
- 230000009027 insemination Effects 0.000 description 4
- 244000144972 livestock Species 0.000 description 4
- 108010035533 Drosophila Proteins Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- 108091000054 Prion Proteins 0.000 description 3
- 102000029797 Prion Human genes 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 210000000349 chromosome Anatomy 0.000 description 3
- 230000009849 deactivation Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 238000004520 electroporation Methods 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000000520 microinjection Methods 0.000 description 3
- 210000003101 oviduct Anatomy 0.000 description 3
- 210000001550 testis Anatomy 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 238000012546 transfer Methods 0.000 description 3
- 210000002268 wool Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- 241000251468 Actinopterygii Species 0.000 description 2
- 108010077805 Bacterial Proteins Proteins 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- 102000014150 Interferons Human genes 0.000 description 2
- 108010050904 Interferons Proteins 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 108091036060 Linker DNA Proteins 0.000 description 2
- 239000004677 Nylon Substances 0.000 description 2
- 238000010222 PCR analysis Methods 0.000 description 2
- 108010090804 Streptavidin Proteins 0.000 description 2
- 238000005411 Van der Waals force Methods 0.000 description 2
- 208000036142 Viral infection Diseases 0.000 description 2
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000009087 cell motility Effects 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 238000007824 enzymatic assay Methods 0.000 description 2
- 210000000918 epididymis Anatomy 0.000 description 2
- 201000010063 epididymitis Diseases 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 208000002672 hepatitis B Diseases 0.000 description 2
- 238000009396 hybridization Methods 0.000 description 2
- 210000004408 hybridoma Anatomy 0.000 description 2
- 239000012678 infectious agent Substances 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000003550 marker Substances 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 229920001778 nylon Polymers 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 210000002966 serum Anatomy 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000005945 translocation Effects 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 1
- 102000040650 (ribonucleotides)n+m Human genes 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- 101100316860 Autographa californica nuclear polyhedrosis virus DA18 gene Proteins 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- 108090001008 Avidin Proteins 0.000 description 1
- 108020004513 Bacterial RNA Proteins 0.000 description 1
- 241000255789 Bombyx mori Species 0.000 description 1
- 101000910039 Bos taurus Alpha-S1-casein Proteins 0.000 description 1
- 102100033029 Carbonic anhydrase-related protein 11 Human genes 0.000 description 1
- 102100033779 Collagen alpha-4(IV) chain Human genes 0.000 description 1
- 102000007644 Colony-Stimulating Factors Human genes 0.000 description 1
- 108010071942 Colony-Stimulating Factors Proteins 0.000 description 1
- 230000004568 DNA-binding Effects 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- 102000003951 Erythropoietin Human genes 0.000 description 1
- 108090000394 Erythropoietin Proteins 0.000 description 1
- 102000001690 Factor VIII Human genes 0.000 description 1
- 108010054218 Factor VIII Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
- 102100031573 Hematopoietic progenitor cell antigen CD34 Human genes 0.000 description 1
- 101000867841 Homo sapiens Carbonic anhydrase-related protein 11 Proteins 0.000 description 1
- 101000710870 Homo sapiens Collagen alpha-4(IV) chain Proteins 0.000 description 1
- 101001075218 Homo sapiens Gastrokine-1 Proteins 0.000 description 1
- 101000777663 Homo sapiens Hematopoietic progenitor cell antigen CD34 Proteins 0.000 description 1
- 101000798114 Homo sapiens Lactotransferrin Proteins 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 241000581650 Ivesia Species 0.000 description 1
- 102000008192 Lactoglobulins Human genes 0.000 description 1
- 108010060630 Lactoglobulins Proteins 0.000 description 1
- 241001529936 Murinae Species 0.000 description 1
- JJIHLJJYMXLCOY-BYPYZUCNSA-N N-acetyl-L-serine Chemical compound CC(=O)N[C@@H](CO)C(O)=O JJIHLJJYMXLCOY-BYPYZUCNSA-N 0.000 description 1
- 108091061960 Naked DNA Proteins 0.000 description 1
- 101100219325 Phaseolus vulgaris BA13 gene Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 108091022908 Serine O-acetyltransferase Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 238000005281 X-ray Gandolfi Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 238000003975 animal breeding Methods 0.000 description 1
- 235000020244 animal milk Nutrition 0.000 description 1
- 238000010420 art technique Methods 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 210000001109 blastomere Anatomy 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002038 chemiluminescence detection Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 230000002759 chromosomal effect Effects 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000009260 cross reactivity Effects 0.000 description 1
- 210000001771 cumulus cell Anatomy 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 210000001671 embryonic stem cell Anatomy 0.000 description 1
- 229940105423 erythropoietin Drugs 0.000 description 1
- ZMMJGEGLRURXTF-UHFFFAOYSA-N ethidium bromide Chemical compound [Br-].C12=CC(N)=CC=C2C2=CC=C(N)C=C2[N+](CC)=C1C1=CC=CC=C1 ZMMJGEGLRURXTF-UHFFFAOYSA-N 0.000 description 1
- 229960005542 ethidium bromide Drugs 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229960000301 factor viii Drugs 0.000 description 1
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 102000050459 human LTF Human genes 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 229940072221 immunoglobulins Drugs 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 229940047124 interferons Drugs 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000008707 rearrangement Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- PYWVYCXTNDRMGF-UHFFFAOYSA-N rhodamine B Chemical compound [Cl-].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=CC=C1C(O)=O PYWVYCXTNDRMGF-UHFFFAOYSA-N 0.000 description 1
- 238000003345 scintillation counting Methods 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000004753 textile Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 238000013519 translation Methods 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
- A01K67/027—New or modified breeds of vertebrates
- A01K67/0275—Genetically modified vertebrates, e.g. transgenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6901—Conjugates being cells, cell fragments, viruses, ghosts, red blood cells or viral vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0006—Modification of the membrane of cells, e.g. cell decoration
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0608—Germ cells
- C12N5/061—Sperm cells, spermatogonia
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Environmental Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Reproductive Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Epidemiology (AREA)
- Developmental Biology & Embryology (AREA)
- Animal Husbandry (AREA)
- Biodiversity & Conservation Biology (AREA)
- Hematology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Materials For Medical Uses (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/537,861 US7067308B1 (en) | 2000-03-28 | 2000-03-28 | Vector for genetically modifying non-human animals |
| US09/537,861 | 2000-03-28 | ||
| PCT/US2001/007018 WO2001073094A2 (en) | 2000-03-28 | 2001-03-05 | Novel sperm-dna complexes for genetically modifying non-human animals |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003528617A true JP2003528617A (ja) | 2003-09-30 |
| JP2003528617A5 JP2003528617A5 (enExample) | 2008-04-03 |
Family
ID=24144410
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2001570810A Pending JP2003528617A (ja) | 2000-03-28 | 2001-03-05 | ヒト以外の動物を遺伝子修飾するための新規なベクター |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7067308B1 (enExample) |
| EP (2) | EP1760155A3 (enExample) |
| JP (1) | JP2003528617A (enExample) |
| CN (1) | CN1432067A (enExample) |
| AR (1) | AR028298A1 (enExample) |
| AT (1) | ATE348184T1 (enExample) |
| AU (1) | AU2001245438A1 (enExample) |
| DE (1) | DE60125156T2 (enExample) |
| PE (1) | PE20011214A1 (enExample) |
| WO (1) | WO2001073094A2 (enExample) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7053187B2 (en) | 2000-03-28 | 2006-05-30 | Gioagri Corporation | Sperm-specific monoclonal antibody, mAbC |
| US7067308B1 (en) * | 2000-03-28 | 2006-06-27 | Bioagri Corporation | Vector for genetically modifying non-human animals |
| US7527966B2 (en) | 2002-06-26 | 2009-05-05 | Transgenrx, Inc. | Gene regulation in transgenic animals using a transposon-based vector |
| NZ597601A (en) | 2007-05-16 | 2013-04-26 | Mat Malta Advanced Technologies Ltd | Treatment and prevention of influenza |
| WO2010036976A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of antibodies |
| WO2010036978A2 (en) | 2008-09-25 | 2010-04-01 | Transgenrx, Inc. | Novel vectors for production of growth hormone |
| EP2417249B1 (en) * | 2009-04-08 | 2022-06-08 | The Regents of The University of California | Dna-cell conjugates |
| EP2417263B1 (en) | 2009-04-09 | 2015-09-23 | ProteoVec Holding L.L.C. | Production of proteins using transposon-based vectors |
| CN102453720B (zh) * | 2010-10-28 | 2013-01-30 | 华中农业大学 | 一种在猪肌肉组织高效表达的融合启动子 |
| SG10201510056SA (en) * | 2011-10-28 | 2016-01-28 | Regeneron Pharma | Genetically modified mice expressing chimeric major histocompatibility complex (mhc) ii molecules |
| US20150024497A1 (en) * | 2013-07-19 | 2015-01-22 | Elwha Llc | Methods and Systems for Utilizing Sperm for Molecular Delivery |
| BR112019025358A2 (pt) | 2017-05-31 | 2020-07-07 | Commonwealth Scientific And Industrial Research Organisation | ovo aviário transgênico, ave transgênica, ovo ou progênie aviária, método para detectar um ovo aviário macho, método para produzir um ovo aviário, método para replicar um vírus, vírus produzidos pelo uso de ovo aviário, método para produzir uma composição de vacina, composição da vacina produzida pelo uso do método e método para produzir um ovo aviário transgênico ou uma ave produzida pelo ovo |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428132A (en) * | 1987-10-11 | 1995-06-27 | United States Of America | Conjugate and method for integration of foreign DNA into cells |
| WO1997011597A1 (fr) * | 1995-09-29 | 1997-04-03 | Hoechst Marion Roussel Ltd. | Obtention d'un animal transgenique |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1228210B (it) | 1989-01-10 | 1991-06-05 | Consiglio Nazionale Ricerche | Procedimento per la introduzione di dna esogeno nelle cellule somatiche e germinali di animali. |
| IL92529A0 (en) | 1989-12-03 | 1990-08-31 | Yissum Res Dev Co | Generation of transgenic vertebrates by employing transformed sperm cells via artificial insemination |
| US5521291A (en) | 1991-09-30 | 1996-05-28 | Boehringer Ingelheim International, Gmbh | Conjugates for introducing nucleic acid into higher eucaryotic cells |
| US6063630A (en) * | 1991-11-05 | 2000-05-16 | Transkaryotic Therapies, Inc. | Targeted introduction of DNA into primary or secondary cells and their use for gene therapy |
| AU2146092A (en) | 1992-05-28 | 1993-12-30 | Scientific Dimensions Usa, Inc. | Transgenic animal production with biolistically transformed spermatozoa |
| RU2081914C1 (ru) | 1994-07-21 | 1997-06-20 | Андрей Вадимович Кузнецов | Способ введения чужеродной днк в сперматозоиды |
| US5744335A (en) | 1995-09-19 | 1998-04-28 | Mirus Corporation | Process of transfecting a cell with a polynucleotide mixed with an amphipathic compound and a DNA-binding protein |
| CN1112165C (zh) | 1997-08-15 | 2003-06-25 | 中国农业大学 | 精子介dna转移生产转基因动物的方法 |
| WO1999038991A1 (en) | 1998-01-28 | 1999-08-05 | Takara Shuzo Co., Ltd. | Method for transferring gene into germ cell |
| NZ506341A (en) | 1998-02-09 | 2003-02-28 | Tranxenogen Inc | Genetic manipulation of spermatogonia |
| IL123411A0 (en) | 1998-02-22 | 1998-09-24 | Kimron Veterinary Inst | High efficiency methods and compositions for integrating exogenous dna into genomic dna of sperm |
| JP2002524054A (ja) | 1998-08-11 | 2002-08-06 | アンソニー・シー・エフ・ペリー | 遺伝子転移を行う方法 |
| US7067308B1 (en) * | 2000-03-28 | 2006-06-27 | Bioagri Corporation | Vector for genetically modifying non-human animals |
| US7053187B2 (en) * | 2000-03-28 | 2006-05-30 | Gioagri Corporation | Sperm-specific monoclonal antibody, mAbC |
-
2000
- 2000-03-28 US US09/537,861 patent/US7067308B1/en not_active Expired - Fee Related
-
2001
- 2001-03-05 AT AT01918350T patent/ATE348184T1/de not_active IP Right Cessation
- 2001-03-05 EP EP06125927A patent/EP1760155A3/en not_active Withdrawn
- 2001-03-05 EP EP01918350A patent/EP1268836B1/en not_active Expired - Lifetime
- 2001-03-05 DE DE60125156T patent/DE60125156T2/de not_active Expired - Lifetime
- 2001-03-05 WO PCT/US2001/007018 patent/WO2001073094A2/en not_active Ceased
- 2001-03-05 AU AU2001245438A patent/AU2001245438A1/en not_active Abandoned
- 2001-03-05 JP JP2001570810A patent/JP2003528617A/ja active Pending
- 2001-03-05 CN CN01810496A patent/CN1432067A/zh active Pending
- 2001-03-27 PE PE2001000287A patent/PE20011214A1/es not_active Application Discontinuation
- 2001-03-28 AR ARP010101471A patent/AR028298A1/es unknown
-
2006
- 2006-04-20 US US11/407,851 patent/US20070214512A1/en not_active Abandoned
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5428132A (en) * | 1987-10-11 | 1995-06-27 | United States Of America | Conjugate and method for integration of foreign DNA into cells |
| WO1997011597A1 (fr) * | 1995-09-29 | 1997-04-03 | Hoechst Marion Roussel Ltd. | Obtention d'un animal transgenique |
Non-Patent Citations (6)
| Title |
|---|
| JPN6010062545, Ｊ． Ｒｅｐｒｏｄ． Ｆｅｒｔｉｌ．, 1983, ｖｏｌ． ６８, ４９７−５０５ * |
| JPN6010062546, Ｔｒａｎｓｇｅｎｉｃ Ｒｅｓ．, 1998, ｖｏｌ． ７, １４７−１５５ * |
| JPN6010062547, Ｈｙｂｒｉｄｏｍａ, 1993, ｖｏｌ． １２, ７０９−７１８ * |
| JPN6010062548, Ｈｕｍ． Ｒｅｐｒｏｄ．, 1996, ｖｏｌ． １１, ２５９５−２５９９ * |
| JPN6010062549, Ｊ． Ｒｅｐｒｏｄ． Ｉｍｍｕｎｏｌ．, 1998, ｖｏｌ． １３, ７３−８４ * |
| JPN6010062550, ＤＮＡ Ｃｅｌｌ Ｂｉｏｌ．, 1997, ｖｏｌ． １６, １０８７−１０９７ * |
Also Published As
| Publication number | Publication date |
|---|---|
| ATE348184T1 (de) | 2007-01-15 |
| EP1268836A2 (en) | 2003-01-02 |
| PE20011214A1 (es) | 2001-11-29 |
| WO2001073094A3 (en) | 2002-05-30 |
| AU2001245438A1 (en) | 2001-10-08 |
| US20070214512A1 (en) | 2007-09-13 |
| CN1432067A (zh) | 2003-07-23 |
| EP1760155A3 (en) | 2007-03-14 |
| EP1268836B1 (en) | 2006-12-13 |
| EP1760155A2 (en) | 2007-03-07 |
| US7067308B1 (en) | 2006-06-27 |
| DE60125156T2 (de) | 2007-09-20 |
| WO2001073094A2 (en) | 2001-10-04 |
| DE60125156D1 (de) | 2007-01-25 |
| AR028298A1 (es) | 2003-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Chang et al. | Effective generation of transgenic pigs and mice by linker based sperm-mediated gene transfer. | |
| US5523222A (en) | Polyelectrolyte DNA conjugation and genetic transformation of an animal | |
| JP5087625B2 (ja) | 非ヒトトランスジェニック動物におけるヒトまたはヒト化免疫グロブリンの発現強化 | |
| JP4102450B2 (ja) | 胎仔線維芽細胞による効率的な核移入 | |
| Heyman | Nuclear transfer: a new tool for reproductive biotechnology in cattle | |
| US20050198698A1 (en) | Production of recombinant polypeptides by bovine species and transgenic methods | |
| JP2000508161A (ja) | キメラ有蹄類及びトランスジェニック有蹄類の生産のための胚幹細胞 | |
| JP2003528617A (ja) | ヒト以外の動物を遺伝子修飾するための新規なベクター | |
| JP4095898B2 (ja) | 人工染色体を含むトランスジェニック動物のクローニング | |
| RU2005117629A (ru) | Трансгенные копытные животные, имеющие пониженную активность прионного белка, и их применения | |
| KR20050000558A (ko) | 인간 항체를 제조할 수 있는 트랜스제닉 유제동물 | |
| JP2005525817A5 (enExample) | ||
| JP2003516134A (ja) | 性染色体特異的タンパク質、種特異的および精子特異的タンパク質、ならびにそれらの同定および単離の方法 | |
| CN106978416B (zh) | 一种基因定位整合表达系统及其应用 | |
| EP0258427A1 (en) | A method for transferring organic substances to egg cells of animals and compositions for use therein | |
| JP4845073B2 (ja) | 再構築受精卵の作製方法及びそれを用いたトランスジェニック胚の作製方法 | |
| EP0350052A2 (en) | Transgenic animals transformed with autonomously replicating sequence-containing plasmid | |
| RU2402211C2 (ru) | Способ получения трансгенных кроликов, продуцирующих белки в молочную железу | |
| US20020194638A1 (en) | Vector for genetically modifying non-human animals | |
| CN100526460C (zh) | 朊病毒蛋白活性降低的转基因有蹄类动物及其用途 | |
| JP7659828B2 (ja) | 遺伝子導入ブタの製造方法、体細胞クローニング原料、遺伝子導入ブタ、樹立された体細胞、及び組織ないし臓器 | |
| AU747070B2 (en) | Efficient nuclear transfer using primordial germ cells | |
| US20030208785A1 (en) | Transgenic pig containing heat shock protein 70 transgene | |
| TWI223585B (en) | Chimeric animal and method for producing the same | |
| Velander | Polyelectrolyte DNA conjugation and genetic transformation of an animal |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080205 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20080205 |
|
| A711 | Notification of change in applicant |
Free format text: JAPANESE INTERMEDIATE CODE: A711 Effective date: 20100924 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A821 Effective date: 20100924 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20101118 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20110414 |